- Forbes. "
Indevus Pharmaceuticals, Inc.,
Formerly Interneuron, to
Begin Trading on Nasdaq".
Indevus Press Release. 2
April 2002. "
Indevus and
PLIVA Sign...
- name to
Indevus Pharmaceuticals and
Cooper remained as CEO
until the
company was
purchased in 2009 by Endo Pharmaceuticals.
While at
Indevus,
Cooper oversaw...
- co-founded
Interneuron Pharmaceuticals in 1988,
which was
renamed to
Indevus in 2002.
Indevus brought an in-licensed product,
Trospium chloride, to
market before...
-
published studies praising the
potential of
pagoclone which were
financed by
Indevus which was s****ing
funding for a
possible production of the compound. The...
- 2022-11-20.
Retrieved 2022-11-20. "DELATESTRYL
Package Insert" (PDF).
Indevus Pharmaceuticals, Inc.
Archived (PDF) from the
original on 2017-02-16. Retrieved...
- Endo
acquired RxKinetix,
leading to a fall in profits. 2009: Endo
bought Indevus Pharmaceuticals to
diversify into
endocrinology and oncology. The company...
-
urination Unusually frequent urination "Manufacturing
Issues Remain for
Indevus' Valstar", U.S. Food and Drug
Administration News. The MQN W****ly Bulletin...
- needed]
Results released in
February 2009 from a
clinical trial of PRO 2000 (
Indevus Pharmaceuticals), a ****l-microbicide gel (0.5%),
sparked hope that it...
- Capital, e.g.,
Morgans Hotel Group '77
Michael W.
Rogers (Berkeley)—CEO of
Indevus, e.g. Histrelin,
NASDAQ Biotechnology Index,
director of
pSividia Limited...
